Our last virtual workshop of the year will focus on the challenges of implementing the new GMP - RDC 301/2019 Annex I (IN35). The Pharma Industry has started this project learning about PIC/s practices and implementing essential changes affecting processes, technology, and people.
After one year, the industry sent doubts and questions to ANVISA. The PDA BRAZIL team worked for two months to prepare responses and will present next week. Our goal is to facilitate your questions and have an open dialogue. We welcome your participation and hope to see you there.